We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Double-bridged Peptide Tailored to Bind Tightly to Disease Targets of Interest

News   May 02, 2018 | Original story from Ecole Polytechnique Fédérale de Lausanne

 
Double-bridged Peptide Tailored to Bind Tightly to Disease Targets of Interest

A model of a double-bridged peptide (the peptide in light blue, the two bridges in yellow). The background of the figures shows many examples of skeletons (also named "scaffolds" or "backbones") of double-bridged peptides. Credit: C. Heinis/EPFL

 
 
 

RELATED ARTICLES

Secrets of Herbal Antidepressant Synthesis Are Uncovered

News

A new collaboration by scientists from German and Canadian research institutes has shed light on the genes involved in the biosynthesis of hypericin.

READ MORE

An Engineered Probiotic Could Be a Novel Treatment Avenue for Inflammatory Bowel Disease

News

A research team has developed a living material approach that uses a strain of genetically engineered E.coli Nissle gut bacteria as a locally acting probiotic.

READ MORE

The Power of Collaboration: Tackling Pharmaceutical Challenges

News

In this article, we explore how pharmaceutical companies have started to embrace a more collaborative way of working as part of a movement to help overcome some of the challenges the industry is facing.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE